Clinical Trials Browser

OTHER × defactinib × Dermatologic × Clear all

NCT06194929 2025-12-03

DETERMINE

Phase 1/2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

NCT04720417 2025-07-15

Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma

Phase 2 Terminated

13 enrolled 13 charts

Uveal Melanoma